Literature DB >> 34545248

A new era in functional genomics screens.

Laralynne Przybyla1,2, Luke A Gilbert3,4,5.   

Abstract

The past 25 years of genomics research first revealed which genes are encoded by the human genome and then a detailed catalogue of human genome variation associated with many diseases. Despite this, the function of many genes and gene regulatory elements remains poorly characterized, which limits our ability to apply these insights to human disease. The advent of new CRISPR functional genomics tools allows for scalable and multiplexable characterization of genes and gene regulatory elements encoded by the human genome. These approaches promise to reveal mechanisms of gene function and regulation, and to enable exploration of how genes work together to modulate complex phenotypes.
© 2021. Springer Nature Limited.

Entities:  

Mesh:

Year:  2021        PMID: 34545248     DOI: 10.1038/s41576-021-00409-w

Source DB:  PubMed          Journal:  Nat Rev Genet        ISSN: 1471-0056            Impact factor:   53.242


  207 in total

Review 1.  Genome editing. The new frontier of genome engineering with CRISPR-Cas9.

Authors:  Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2014-11-28       Impact factor: 47.728

Review 2.  CRISPR technologies for precise epigenome editing.

Authors:  Muneaki Nakamura; Yuchen Gao; Antonia A Dominguez; Lei S Qi
Journal:  Nat Cell Biol       Date:  2021-01-08       Impact factor: 28.824

Review 3.  Editing the Epigenome: Reshaping the Genomic Landscape.

Authors:  Liad Holtzman; Charles A Gersbach
Journal:  Annu Rev Genomics Hum Genet       Date:  2018-05-31       Impact factor: 8.929

Review 4.  CRISPR/Cas9 in Genome Editing and Beyond.

Authors:  Haifeng Wang; Marie La Russa; Lei S Qi
Journal:  Annu Rev Biochem       Date:  2016-04-25       Impact factor: 23.643

Review 5.  Design and analysis of CRISPR-Cas experiments.

Authors:  Ruth E Hanna; John G Doench
Journal:  Nat Biotechnol       Date:  2020-04-13       Impact factor: 54.908

Review 6.  High-throughput functional genomics using CRISPR-Cas9.

Authors:  Ophir Shalem; Neville E Sanjana; Feng Zhang
Journal:  Nat Rev Genet       Date:  2015-04-09       Impact factor: 53.242

Review 7.  Am I ready for CRISPR? A user's guide to genetic screens.

Authors:  John G Doench
Journal:  Nat Rev Genet       Date:  2017-12-04       Impact factor: 53.242

Review 8.  The next generation of CRISPR-Cas technologies and applications.

Authors:  Adrian Pickar-Oliver; Charles A Gersbach
Journal:  Nat Rev Mol Cell Biol       Date:  2019-08       Impact factor: 94.444

9.  Perturb-Seq: Dissecting Molecular Circuits with Scalable Single-Cell RNA Profiling of Pooled Genetic Screens.

Authors:  Atray Dixit; Oren Parnas; Biyu Li; Jenny Chen; Charles P Fulco; Livnat Jerby-Arnon; Nemanja D Marjanovic; Danielle Dionne; Tyler Burks; Raktima Raychowdhury; Britt Adamson; Thomas M Norman; Eric S Lander; Jonathan S Weissman; Nir Friedman; Aviv Regev
Journal:  Cell       Date:  2016-12-15       Impact factor: 41.582

Review 10.  CRISPR-Cas guides the future of genetic engineering.

Authors:  Gavin J Knott; Jennifer A Doudna
Journal:  Science       Date:  2018-08-31       Impact factor: 47.728

View more
  11 in total

1.  Decoding the IGF1 signaling gene regulatory network behind alveologenesis from a mouse model of bronchopulmonary dysplasia.

Authors:  Feng Gao; Changgong Li; Susan M Smith; Neil Peinado; Golenaz Kohbodi; Evelyn Tran; Yong-Hwee Eddie Loh; Wei Li; Zea Borok; Parviz Minoo
Journal:  Elife       Date:  2022-10-10       Impact factor: 8.713

Review 2.  A guide to systems-level immunomics.

Authors:  Lorenzo Bonaguro; Jonas Schulte-Schrepping; Thomas Ulas; Anna C Aschenbrenner; Marc Beyer; Joachim L Schultze
Journal:  Nat Immunol       Date:  2022-09-22       Impact factor: 31.250

3.  Mapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seq.

Authors:  Joseph M Replogle; Reuben A Saunders; Angela N Pogson; Jeffrey A Hussmann; Alexander Lenail; Alina Guna; Lauren Mascibroda; Eric J Wagner; Karen Adelman; Gila Lithwick-Yanai; Nika Iremadze; Florian Oberstrass; Doron Lipson; Jessica L Bonnar; Marco Jost; Thomas M Norman; Jonathan S Weissman
Journal:  Cell       Date:  2022-06-09       Impact factor: 66.850

4.  Paired guide RNA CRISPR-Cas9 screening for protein-coding genes and lncRNAs involved in transdifferentiation of human B-cells to macrophages.

Authors:  Carme Arnan; Sebastian Ullrich; Carlos Pulido-Quetglas; Ramil Nurtdinov; Alexandre Esteban; Joan Blanco-Fernandez; Estel Aparicio-Prat; Rory Johnson; Sílvia Pérez-Lluch; Roderic Guigó
Journal:  BMC Genomics       Date:  2022-05-26       Impact factor: 4.547

Review 5.  Fine mapping with epigenetic information and 3D structure.

Authors:  Gisela Orozco
Journal:  Semin Immunopathol       Date:  2022-01-12       Impact factor: 9.623

6.  Computational and experimental methods for classifying variants of unknown clinical significance.

Authors:  Malte Spielmann; Martin Kircher
Journal:  Cold Spring Harb Mol Case Stud       Date:  2022-04-28

7.  CRISPR-surfaceome: An online tool for designing highly efficient sgRNAs targeting cell surface proteins.

Authors:  Hong Mei; Qian Gu; Wei Wang; Yu Meng; Lichun Jiang; Jia Liu
Journal:  Comput Struct Biotechnol J       Date:  2022-07-18       Impact factor: 6.155

Review 8.  Posttranslational regulation of the GCN5 and PCAF acetyltransferases.

Authors:  Onyekachi E Ononye; Michael Downey
Journal:  PLoS Genet       Date:  2022-09-15       Impact factor: 6.020

Review 9.  Big data in basic and translational cancer research.

Authors:  Peng Jiang; Sanju Sinha; Kenneth Aldape; Sridhar Hannenhalli; Cenk Sahinalp; Eytan Ruppin
Journal:  Nat Rev Cancer       Date:  2022-09-05       Impact factor: 69.800

10.  Accounting for small variations in the tracrRNA sequence improves sgRNA activity predictions for CRISPR screening.

Authors:  Peter C DeWeirdt; Abby V McGee; Fengyi Zheng; Ifunanya Nwolah; Mudra Hegde; John G Doench
Journal:  Nat Commun       Date:  2022-09-06       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.